75693-16-2Relevant articles and documents
GLP-1R AGONISTS AND USES THEREOF
-
Page/Page column 64; 121-122, (2020/06/10)
Provided are compounds of Formula (I) and pharmaceutical compositions thereof, for use in, e.g. treating type 2 diabetes mellitus, pre-diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and cardiovascular disease.
Catalytic asymmetric intermolecular bromoesterification of unfunctionalized olefins
Li, Lijun,Su, Cunxiang,Liu, Xiaoqin,Tian, Hua,Shi, Yian
supporting information, p. 3728 - 3731 (2014/08/05)
An asymmetric intermolecular bromoesterification of unfunctionalized olefins catalyzed by (DHQD)2PHAL is described. Optically active bromoesters can be obtained with up to 92% ee.